Mycobacterium bovis Bacillus Calmette-Guérin cell wall component

The **cell wall components** of *Mycobacterium bovis* Bacillus Calmette-Guérin (BCG) comprise a complex structure containing **mycolic acid, arabinogalactan, and peptidoglycan**[2][4][5]. These form the basis of the **BCG cell wall skeleton (BCG-CWS)**, a clinically used immunological adjuvant and investigational therapeutic agent. BCG-CWS acts as a **pathogen-associated molecular pattern (PAMP)** recognized by innate immune receptors, triggering **TLR2- and TLR4-dependent pathways**—this results in activation and maturation of antigen-presenting cells like dendritic cells and monocytes[2][6]. Components such as **arabino-mycolates** are specifically implicated in robust induction of **tumor necrosis factor alpha (TNF-α)** and other pro-inflammatory cytokines, predominantly through **TLR2/MyD88 pathways**[5]. BCG-CWS has been exploited as an adjuvant in vaccine formulations (against tuberculosis and cancer)[2][6], and it exhibits unique modulation of immune-related gene expression distinct from classic PAMPs such as lipopolysaccharide[2]. The entry is marked as **is_incorrect: true** because the "target" name refers to a **complex, structurally heterogeneous mixture** rather than a single molecular entity—this violates conventions for molecular target records, as it is not a receptor, enzyme, transporter, or defined protein but an aggregate of cell wall molecules[2][4][5]. No known abbreviation is widely accepted. While key components (like arabinogalactan, mycolic acid, and peptidoglycan) are well described, the full mixture's exact specification and effect on pharmacological targeting require context-specific clarification.

Other names

BCG-CWSBCG cell wall skeletonMycobacterium bovis cell wall component

Immunostimulation via Toll-like receptor 2 (TLR2) and TLR4 signaling, Induction of cytokine production (e.g. TNF-α, IL-23), Modulation of dendritic cell maturation